From One-Size-Fits-All to Mechanism-Guided Treatment for Intracranial Hemorrhage.

From One-Size-Fits-All to Mechanism-Guided Treatment for Intracranial Hemorrhage.
复制标题

从一刀切到机制引导的颅内出血治疗。

DOI:
10.1097/ccm.0000000000004055
复制
发表时间:
2019
影响因子:
8.8
通讯作者:
Naidech,AndrewM
Naidech,AndrewM
中科院分区:
医学1区
文献类型:
--
作者:
Naidech,AndrewM

文献摘要

参考文献

相似文献

Naidech 博士的机构获得了美国国立卫生研究院 (NIH)/国立神经疾病和中风研究所的资助。他透露,他已获得重症监护医学学会和美国神经病学学会的演讲稿费,并且他被列为一项在最早时间 (FASTEST) 进行的因子 VII、FVIIa 治疗急性出血性中风临床试验的多重首席研究员,该试验预计于 2020 年开始;他还获得了美国国立卫生研究院 (NIH) 的文章研究支持。
Dr. Naidech’s institution received funding from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke. He disclosed that he had received royalties from the Society of Critical Care Medicine and the American Academy of Neurology for speaking, and he is listed as a Multiple Principal Investigator for a clinical trial of Factor VII, FVIIa for Acute hemorrhagic STroke administered at Earliest Time (FASTEST), slated to start in 2020; and he received support for article research from the NIH.
DOI: 10.1161/jaha.116.005356
发表时间: 2017-07-21
影响因子: 5.4
作者:
Katzan IL;Thompson NR;Lapin B;Uchino K
通讯作者: Uchino K
DOI: 10.1161/strokeaha.109.561712
发表时间: 2010-01-01
期刊: STROKE
影响因子: 8.3
作者:
Diringer, Michael N.;Skolnick, Brett E.;Broderick, Joseph P.
通讯作者: Broderick, Joseph P.
DOI: 10.1097/ccm.0000000000001082
发表时间: 2015-08
影响因子: 8.8
作者:
Naidech AM;Beaumont JL;Berman M;Francis B;Liotta E;Maas MB;Prabhakaran S;Holl J;Cella D
通讯作者: Cella D
DOI: 10.1161/strokeaha.114.006061
发表时间: 2014-08
期刊: Stroke
影响因子: 8.3
作者:
Naidech AM;Maas MB;Levasseur-Franklin KE;Liotta EM;Guth JC;Berman M;Rosenow JM;Lindholm PF;Bendok BR;Prabhakaran S;Bernstein RA;Kwaan HC
通讯作者: Kwaan HC
血小板活性降低与脑出血后早期血栓生长和更糟糕的 3 个月结果相关
DOI: --
发表时间: 2009
期刊: Stroke
影响因子: 8.3
作者:
A. Naidech;B. Jovanovic;S. Liebling;Rajeev K. Garg;S. Bassin;B. Bendok;Richard A. Bernstein;Mark J. Alberts;H. Batjer
通讯作者: H. Batjer